Superiority:
Factory high quality >=94% (OraRez W) reasonable price 25153-40-6
METHYL VINYL ETHER/MALEIC ACID COPOLYMER Basic information
Product Name: METHYL VINYL ETHER/MALEIC ACID COPOLYMER
Synonyms: (Z)-but-2-enedioic acid,methoxyethene;methylvinylether/maleicacidcopolymer,lowmolecularweight;polymerwithmethoxyethene;POLY(METHYL VINYL ETHER/MALEIC ACID)*HIG H MOLECULAR;POLY(METHYL VINYL ETHER-CO-MALEIC ACID), AVE. M.N. 20,000;POLY(METHYL VINYL ETHER-CO-MALEIC ACID), AVERAGE MN CA. 67,000 (MO);Methyl vinyl ether/maleic acid copolymer, high molecular weight;2-Butenedioic acid (2Z)-, polymer with methoxyethene
CAS: 25153-40-6
MF: C21H30O15X2
MW: 522.45
EINECS:
Product Categories: Polymers;Acrylics;Hydrophilic Polymers;Maleic Anhydride Copolymers;Maleic Anhydride Copolymers;Hydrophilic Polymers;Materials Science;Polymer Science
Mol File: 25153-40-6.mol
METHYL VINYL ETHER/MALEIC ACID COPOLYMER Structure
Excellent bioadhesive/mucoadhesive properties; excellent chelating properties;Enhances solubilization and retention of actives and drugs;
Details:
Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) was the first domestic company to develop and manufacture polyvinylpyrrolidone (PVP) series products in China. With more than 27 year’s experience in PVP production coupled to a dedicated commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP’s and third largest globally.
In April of 2013, construction of NKY’s new plant with 138,800 m2of land and 50,000 m2of structure was completed, making it the production center for our PVP and PVM/MA polymer families. The new facilities includes production capacity of: 12,000 tons/year GBL; 5,000 tons/year 2-pyrrolidone; 5,000 tons/year NVP; 2,500 tons/year PVM/MA copolymer; 2,000 tons/year MVE and 5,000
Customer first: quality first, continuous innovation, the pursuit of excellence.
Business purpose: research and development of functional polymer new products, leading human life.
Business philosophy: quality management is the program of our management, technical innovation is the
fundamental to our survival, customer satisfaction is the yardstick to measure our
work, the creation of brand name is our goal.
-
Boai NKY participates in the In-Cosmetics Global 2019 held in Paris
On April 2, 2019, In-Cosmetics 2019 international Cosmetics raw material exhibition was held In Paris, the ancient capital of France.Enhance customer service and product innovationBoai NKY has set up a new research and development center at its headquarters in jiaozuo, China.The 6,200 sq m facility contains the latest synthesis, process and analytical equipment to support our new product development and customer service capabilities.Combined with the r&d center is a complete pilot facility capable of producing 1-1000 kg of products.The facility will enhance boai's internal operations and make it available to customers to assist in their own product development and commercialization activities.With the emphasis on research and development, the personal care market has launched three new products:PiloRez hs-564: this new hair polymer has high gloss, strong adhesion, good toughness and other characteristics.DermaRez Protect 216 and 220: this material is waterproof, film forming and dispersant, especially suitable for sun protection and makeup applications.New open source has been trying to provide customers with high-quality products, is constantly exploring and introducing the latest technology, production of quality products, efforts to improve the quality management system, enhance the strength of research and development;At the same time, the competitive technical team, continuous improvement of the quality management system and perfect after-sales service is the customer convinced that the choice of the right raw material supply partners!
Read more<<
-
2019-04-042019 Boai NKY product promotion and seminar-- Malaysia and Indonesia
Boai Nky Pharmaceuticals Ltd. 's annual product roadshow 2019 was successfully held in Malaysia and Indonesia from March 25 to 28.New open source of Indonesia product promotion conference took a group photo with the sponsor Narda Tita and the customer representatives presentDr. Herbert Ulmer (fifth from right), chief scientist of new open source in Indonesia product promotion conference, Mr. Wojciech Bobecki (fourth from right), deputy general manager of new open source Germany branch, Mr. Wang long (third from right), assistant general manager of tianjin new open source international trade co., LTD., and the organizer Narda Tita took a group photoThis tour is the prelude of the important market promotion project of new open source in southeast Asia market. In the later stage, new open source will increase the strength of customer service and technical support, and further cooperate with customers to deepen the mutual communication and the concept of collaborative research and development.In this tour promotion activity, the majority of customers deeply realized the strength of the new open source company and the reliability of the product, and we greatly welcome the new open source company's technical marketing team to go deep into the customer's side to provide customers with tailored solutions according to local conditions.Dr Herbert Ulmer, chief scientist of the new open source product launch in IndonesiaMr. Wang longNew open source not only provides high quality pharmaceutical accessories products, but also provides all the regulations, supply chain, environmental protection and technical support for products and formulations required by the pharmaceutical industry. What we provide is a complete set of pharmaceutical accessories product solutions.It is believed that in the near future, new open source will set up the brand image of high quality solution provider in the new pharmaceutical accessory industry in southeast Asia and even the whole world.
Read mor2019-04-08
-
Delegation from California USA visits Boai NKY
On the afternoon of April 6, 2019, a delegation of 19 guests from California state administration of politics and business attended the henan international investment fair, led by May
Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) was the first domestic company to develop and manufacture polyvinylpyrrolidone (PVP) series products in China. With more than 27 year’s experience in PVP production coupled to a dedicated commitment to quality improvement and management, NKY has become the largest Chinese producer of PVP’s and third largest globally.
In April of 2013, construction of NKY’s new plant with 138,800 m2of land and 50,000 m2of structure was completed, making it the production center for our PVP and PVM/MA polymer families. The new facilities includes production capacity of: 12,000 tons/year GBL; 5,000 tons/year 2-pyrrolidone; 5,000 tons/year NVP; 2,500 tons/year PVM/MA copolymer; 2,000 tons/year MVE and 5,000